You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gemox

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial in Tianjin (Sintilimab, IBI305, GEMOX)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Feb 22, 2022

Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)

Active, not recruiting
  • Advanced Primary Liver Cancer
  • Advanced Biliary Tract Carcinoma
  • SHR-1210
  • +3 more
  • Zhengzhou, Henan, China
  • +1 more
Apr 26, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Belgium, Italy, Spain (BI 836826, GemOx, Rituximab)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • BI 836826
  • +2 more
  • Hasselt, Belgium
  • +6 more
Mar 13, 2019

Digestive Cancer Trial in Montpellier (Regorafenib, GEMOX)

Completed
  • Digestive Cancer
  • Montpellier, France
    Centre Val d'Aurelle
Jan 7, 2020

Hepatocellular Carcinoma Trial (GEMOX, FOLFOX4)

Withdrawn
  • Hepatocellular Carcinoma
  • (no location specified)
Jun 1, 2019

Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (biological test, GEMOX, Cetuximab)

Unknown status
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Gallbladder Cancer
  • biological test
  • +8 more
  • Shanghai, Shanghai, China
    Xinhua Hospital
May 4, 2018

Advanced Urothelial Carcinoma Trial in Daegu, Daejeon, Seoul (GCb, GemOx)

Unknown status
  • Advanced Urothelial Carcinoma
  • Daegu, Korea, Republic of
  • +4 more
Sep 22, 2014

Prostate Cancer Trial in Seoul (GEMOX)

Completed
  • Prostate Cancer
  • GEMOX
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 30, 2013